getting glp 1 in canada WHO backs GLP-1 meds to treat obesity, but many Islanders can't access them Cheaper obesity medications could come
Description
Ligibel: Do these drugs actually reduce the risk of developing cancer

The original development partner, Janssen Pharmaceuticals, has handed back the license for efinopegdutide to the original developer, Hanmi Pharmaceutical, but the license has been taken up by Merck to be developed as a once weekly treatment for NAFLD

The company launched its once-weekly GLP-1 injection Xinermei in July, entering the market after Novos Wegovy and Eli Lillys Mounjaro

Cao G, Fehrenbach ML, Williams JT, Finklestein JM, Zhu JX, Delisser HM
